Correlation Between Kronos Bio and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Kronos Bio and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Mineralys Therapeutics,.
Diversification Opportunities for Kronos Bio and Mineralys Therapeutics,
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Kronos and Mineralys is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Kronos Bio i.e., Kronos Bio and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Kronos Bio and Mineralys Therapeutics,
Given the investment horizon of 90 days Kronos Bio is expected to generate 0.75 times more return on investment than Mineralys Therapeutics,. However, Kronos Bio is 1.33 times less risky than Mineralys Therapeutics,. It trades about 0.0 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest 98.00 in Kronos Bio on August 30, 2024 and sell it today you would lose (2.00) from holding Kronos Bio or give up 2.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kronos Bio vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Kronos Bio |
| Mineralys Therapeutics, |
Kronos Bio and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kronos Bio and Mineralys Therapeutics,
The main advantage of trading using opposite Kronos Bio and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Kronos Bio vs. Cyclerion Therapeutics | Kronos Bio vs. Larimar Therapeutics | Kronos Bio vs. Addex Therapeutics | Kronos Bio vs. Achilles Therapeutics PLC |
| Mineralys Therapeutics, vs. Evolution Gaming Group | Mineralys Therapeutics, vs. Mativ Holdings | Mineralys Therapeutics, vs. CF Industries Holdings | Mineralys Therapeutics, vs. The Mosaic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |